 |
This Is MS Multiple Sclerosis Community: Knowledge & SupportWelcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones. |
| It is currently Tue Jun 18, 2013 7:20 pm |
|
All times are UTC - 8 hours [ DST ] |
 
|
Page 1 of 1 |
[ 1 post ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| DenverCO |
|
|||||
Joined: Wed Nov 24, 2004 4:00 pm Posts: 117 |
|
|||||
| Top |  |
|||||
 |
||||||
|
|
Page 1 of 1 |
[ 1 post ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
 | Ampyra Approved | 7 | 2216 | Sat Jun 12, 2010 5:28 am | |
| Would like to hear from people using Ampyra... | 2 | 321 | Fri Sep 07, 2012 8:21 pm | |
| Acorda Gets FDA Marketing Approval For Ampyra (Fampridine) | 6 | 1447 | Fri Jan 29, 2010 1:43 pm | |
| New Ampyra(R) (dalfampridine) study data reported at ECTRIMS | 0 | 712 | Fri Oct 15, 2010 10:18 am | |
| Additional phase 3 clinical trial data for Ampyra released | 0 | 728 | Wed Nov 17, 2010 8:04 am | |
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |
News 
Site map 
SitemapIndex 
RSS Feed Channel list
Login
Register
FAQ
